Most Appropriate Initial Investigation: Serum Ferritin and Transferrin Saturation
In this 25-year-old man with classic hemochromatosis features (lethargy, joint pain, skin pigmentation, hepatomegaly, and elevated fasting glucose), the most appropriate initial investigation is D - Ferritin saturation (meaning serum ferritin AND transferrin saturation together). This represents the standard first-line diagnostic approach for suspected hereditary hemochromatosis.
Rationale Based on Guidelines
The clinical presentation is highly suggestive of hemochromatosis with multiple organ involvement:
- Hepatomegaly (liver involvement)
- Hyperglycemia (FBS 15 mmol/L = ~270 mg/dL, indicating pancreatic involvement/diabetes)
- Skin hyperpigmentation (classic "bronze diabetes")
- Joint pain (arthropathy)
- Lethargy (systemic manifestation)
Why Ferritin and Transferrin Saturation First?
Multiple authoritative guidelines consistently recommend this approach 1, 2, 3, 2:
The AASLD 2011 guidelines explicitly state: "In a patient with suggestive symptoms, physical findings, or family history, a combination of TS and ferritin should be obtained rather than relying on a single test" 2. This is a Grade 1B recommendation.
The diagnostic algorithm is stepwise:
Step 1 - Initial screening: Measure fasting transferrin saturation (TS) and serum ferritin
Step 2 - If Step 1 abnormal: Proceed to HFE genetic testing (C282Y and H63D mutations)
Step 3 - If needed: Liver biopsy for hepatic iron concentration and histopathology, particularly if ferritin >1000 µg/L 2
Why NOT the Other Options?
A - Alpha-fetoprotein: This is a tumor marker for hepatocellular carcinoma. While hemochromatosis increases HCC risk, AFP is not a diagnostic test for hemochromatosis itself. It would only be indicated if cirrhosis is confirmed and HCC surveillance is needed.
B - Ultrasound HBS (hepatobiliary system): Imaging is not the initial diagnostic test. While ultrasound may show hepatomegaly (already detected clinically), it cannot diagnose hemochromatosis. MRI can detect iron deposition but comes later in the diagnostic algorithm 2.
C - Genetic study: While ultimately important, genetic testing is Step 2, not Step 1. The AASLD and EASL guidelines are clear that phenotypic testing (ferritin/TS) precedes genotypic testing 2, 4, 2. Genetic testing should only be performed after abnormal iron studies are documented 1.
E - Peripheral blood film: This is not indicated for hemochromatosis diagnosis. The hemoglobin is normal (16 g/dL), and there's no suggestion of hemolytic anemia or other hematologic disorder requiring blood film examination.
Clinical Context and Pitfalls
Important considerations:
Ferritin can be falsely elevated in inflammatory conditions, liver disease, malignancy, and metabolic syndrome 2. However, when both ferritin and transferrin saturation are elevated together, this significantly increases specificity for iron overload.
Transferrin saturation >45% is the most sensitive screening test for hemochromatosis, though it has lower specificity 2. Using both tests together maximizes diagnostic accuracy.
In this young patient (25 years) with multiple organ involvement, the ferritin level will likely be significantly elevated, potentially >1000 µg/L, which would predict advanced disease and possible cirrhosis 2.
The elevated bilirubin (TB 20) with relatively modest ALT elevation (59) suggests possible hepatic dysfunction from iron overload, making early diagnosis critical.
Expected Findings and Next Steps
Based on the clinical presentation, you should expect:
- Transferrin saturation: Likely 80-100% (normal 20-50%)
- Serum ferritin: Likely 500-6000 µg/L in symptomatic patients (normal 20-200 µg/L in men) 2
If both are elevated: Proceed immediately to HFE genetic testing (C282Y/H63D mutations) 2.
If ferritin >1000 µg/L with elevated liver enzymes: Consider liver biopsy to assess for cirrhosis, as this patient is at high risk given the young age with symptomatic disease 2.
The combination of serum ferritin and transferrin saturation provides the most cost-effective, evidence-based initial diagnostic approach for this patient with classic hemochromatosis presentation 1, 3, 1.